To circumvent these confounding effects of whole biopsy gene expression analysis, we subsequently immunohistochemically analyzed nuclear C/EBPδ protein levels in tumor cells of a cohort of 67 pancreatic ductal adenocarcinoma patients using normal duct epithelium as control. The gene discussed is CEBPD; the disease is pancreatic ductal adenocarcinoma.